HHS plans two new FDA deputy roles

HHS is planning two new deputy commissioner roles at the FDA: one for technology and AI, and another for drugs. No final decisions have been announced, and FDA leadership remains unsettled as Heidi Overton awaits Senate confirmation. Jared Seehafer is identified as the leading candidate for the technology post, leveraging his Enzyme background and FDA advisory experience. Kyle Diamantas has served as acting commissioner and may or may not return to that role. The move is part of a broader effort by the Trump administration to influence the agency amid leadership turbulence after Marty Makary's departure. Multiple outlets have reported the plan, with CNBC as the primary source and others echoing the details.